Suppr超能文献

腓骨游离皮瓣和髂嵴游离皮瓣在下颌成釉细胞瘤患者下颌骨重建中的应用

Fibular Free Flap and Iliac Crest Free Flap Mandibular Reconstruction In Patients With Mandibular Ameloblastomas.

作者信息

Piotrowska-Seweryn Agnieszka, Szymczyk Cezary, Walczak Dominik A, Krakowczyk Łukasz, Maciejewski Adam, Hadasik Grzegorz, Wierzgoń Janusz, Szumniak Ryszard, Drozdowski Piotr, Paul Piotr, Grajek Maciej

机构信息

Department of Oncological and Reconstructive Surgery, Maria Sklodowska-Curie National Research Institute of Oncology.

Tumor Pathology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch, Poland.

出版信息

J Craniofac Surg. 2022 Oct 1;33(7):1962-1970. doi: 10.1097/SCS.0000000000008524. Epub 2022 Feb 16.

Abstract

Ameloblastoma (AM) is the most common, locally aggressive odontogenic tumor. It comprises about 1% of all head and neck neoplasms. It occurs mainly in young adults in their 3rd and 4th decade of life. It localizes in the mandible in about 80% of the cases. According to the 2017 WHO classification, 4 types of ameloblastoma can be distinguished: ameloblastoma (previously referred to as solid/multicystic-SMA; the "conventional type" AM), unicystic (AM-UA), extraosseous/peripheral (AM-PA), and malignant/metastatic (AM-MA). Solid, multicystic is the most common type. It is characteristic for its aggressiveness and high risk of recurrence. Radical resection with consecutive reconstruction is the treatment of choice of mandibular ameloblastomas.In this study, the authors present their experience in the surgical treatment of mandibular ameloblastomas with vascularized free flap reconstructions. They discuss new technological possibilities that could improve the precision of the reconstructive procedure and therefore result in the better aesthetic outcome.The retrospective study of a group of 21 patients suffering from mandibular ameloblastoma who underwent segmental man-dibulectomy with simultaneous microvascular free flap reconstruction was conducted. A thorough clinical analysis with various aspects was performed. Tumors resected before 2017 were double checked patomorphologically and assigned to the corrected subtype group.Seven patients were admitted to the department due to recurrent ameloblastoma. The most common localization of the tumor was the mandibular body ( n = 6) andbodywith ramus of the mandible ( n = 6). A total amount of 10 iliac crest free flaps and 12 fibular free flaps were performed. Complications were reported in 4 patients. A purulent oro-cutaneus fistula occurred in 3 patients. There was a flap failure in each reconstructive group. The virtual surgical planning with intraoperative cone-beam computed tomography was used in 3 patients. Dentition implantation was conducted in 4 patients (3 simultaneously, 1 postponed). The mean follow-up was 5 years and 8 months.Radical resection that covers radical segmental mandibulect-omy with immediate microvascular free flap reconstruction is a first-line and only effective treatment of mandibular ameloblas-tomas, that eliminates the risk of recurrence. The extent of surgical margins seems not to influence the recurrence rate, yet further investigation with statistical analysis should be performed. The choice of the adequate free flap must be adapted to dimensions and localization of the tumor and to each patient individually.New technologies such as virtual surgical planning with 3D models and intraoperative cone-beam computed tomography can make the reconstruction more accurate, improving patient's quality of life.

摘要

成釉细胞瘤(AM)是最常见的具有局部侵袭性的牙源性肿瘤。它约占所有头颈部肿瘤的1%。主要发生于30至40岁的年轻人。约80%的病例发生在下颌骨。根据2017年世界卫生组织分类,可区分出4种类型的成釉细胞瘤:成釉细胞瘤(以前称为实性/多囊性-SMA;“传统型”AM)、单囊性(AM-UA)、骨外/外周性(AM-PA)和恶性/转移性(AM-MA)。实性、多囊性是最常见的类型。其特点是具有侵袭性和高复发风险。根治性切除并连续重建是下颌成釉细胞瘤的首选治疗方法。在本研究中,作者介绍了他们采用带血管游离皮瓣重建术治疗下颌成釉细胞瘤的经验。他们讨论了可以提高重建手术精度从而获得更好美学效果的新技术可能性。对一组21例患有下颌成釉细胞瘤并接受节段性下颌骨切除术同时进行微血管游离皮瓣重建的患者进行了回顾性研究。进行了全面的多方面临床分析。对2017年之前切除的肿瘤进行了病理复查,并归入校正后的亚型组。7例患者因复发性成釉细胞瘤入院。肿瘤最常见的部位是下颌体(n = 6)和下颌体与下颌支(n = 6)。共进行了10例髂嵴游离皮瓣和12例腓骨游离皮瓣手术。4例患者报告有并发症。3例患者出现脓性口皮瘘。每个重建组都有皮瓣失败的情况。3例患者使用了术中锥形束计算机断层扫描的虚拟手术规划。4例患者进行了牙列植入(3例同时进行,1例延期)。平均随访时间为5年8个月。根治性切除包括根治性节段性下颌骨切除术并立即进行微血管游离皮瓣重建,是下颌成釉细胞瘤的一线且唯一有效的治疗方法,可消除复发风险。手术切缘的范围似乎不影响复发率,但应进行进一步的统计分析研究。合适的游离皮瓣的选择必须根据肿瘤的大小和部位以及每个患者的个体情况进行调整。诸如使用3D模型的虚拟手术规划和术中锥形束计算机断层扫描等新技术可以使重建更加精确,提高患者的生活质量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验